Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Brachytherapy|December 10, 2019
Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapyMartin C Tom, Chandana A Reddy, Timothy D Smile, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Brachytherapy|October 17, 2021
125I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancerTimothy D Smile, Martin C Tom, Ahmed Halima, et al.
European Urology Open Science|March 2, 2026
Divergent Differentiation and Histologic Subtypes in Upper Tract Urothelial Carcinoma Demonstrate Distinct Patterns of Extraurothelial RecurrenceBetty Wang, Laura E Davis, Devika Nandwana, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
The Journal of Urology|May 9, 2017
Renal Mass and Localized Renal Cancer: AUA GuidelineSteven Campbell, Robert G Uzzo, Mohamad E Allaf, et al.
Urology|July 30, 2023
AI-generated R.E.N.A.L.+ Score Surpasses Human-generated Score in Predicting Renal Oncologic OutcomesNour Abdallah, Andrew Wood, Tarik Benidir, et al.
Clinical Genitourinary Cancer|April 29, 2020
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall SurvivalJaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Targeted Oncology|March 25, 2020
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial CarcinomaIris Y Sheng, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Pageof 16